Qatar vs Sierra Leone: HIV-positive TB patients on ART (antiretroviral therapy)
Qatar
100.0%
in 2024
Sierra Leone
100.0%
in 2024
Qatar rank
1st
Sierra Leone rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Qatar
- Sierra Leone
How they compare
Qatar currently reports 100.0% against 100.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 1 time across 8 shared years of data; in 2012 it was Qatar ahead.
Qatar ranks 1st and Sierra Leone ranks 1st of 144 countries.
Qatar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Qatar | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 88.7% | 11.3% | Qatar |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Qatar or Sierra Leone?
- Qatar, at 100.0% against 100.0% in Sierra Leone as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Qatar and Sierra Leone?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Sierra Leone?
- 8 years are reported by both, from 2012 to 2024.
- How do Qatar and Sierra Leone rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Qatar ranks 1st and Sierra Leone ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.